Conmed (CNMD) EBITDA Margin Growth (1y) (2011 - 2026)
Conmed (CNMD) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 146.00 |
| 10 | Conmed | 1.54 Bn | 1.50 Bn | 197.46 Mn | -55.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -55.00 |
| Mar 31, 2026 | 305.00 |
| Dec 31, 2025 | -536.00 |
| Sep 30, 2025 | -1,723.00 |
| Jun 30, 2025 | -304.00 |
| Mar 31, 2025 | -624.00 |
| Dec 31, 2024 | -17.00 |
| Sep 30, 2024 | 1,080.00 |
| Jun 30, 2024 | 555.00 |
| Mar 31, 2024 | 691.00 |
| Dec 31, 2023 | 1,578.00 |
| Sep 30, 2023 | 113.00 |
| Jun 30, 2023 | -19.00 |
| Mar 31, 2023 | -496.00 |
| Dec 31, 2022 | -1,402.00 |
| Sep 30, 2022 | -192.00 |
| Jun 30, 2022 | -125.00 |
| Mar 31, 2022 | 63.00 |
| Dec 31, 2021 | 381.00 |
| Sep 30, 2021 | -162.00 |